Expand the following panels for additional search options.

What factors contribute to inconsistent business valuation multiples?

Three professors at the Leipzig Graduate School of Management reviewed 1,149 recent private equity cross-border transactions to determine the consistency of the business valuation metrics.

BVU News and Trends August 2020

A monthly roundup of key developments of interest to business valuation experts.

D&P offers infographic on cost of capital amid COVID-19

Which financial market and economic indicators did Duff & Phelps take into consideration when it arrives at its recommended U.S. equity risk premium and accompanying normalized risk-free rate?

The Market Price of Risk: Quantifying a COVID-19 Equity Risk Premium Using High-Yield Bond Pricing

The authors demonstrate how a high-yield option-adjusted spread is used when doing appraisals of private companies while considering the market volatility and economic slowdown caused by the COVID-19 pandemic.

BVU News and Trends July 2020

A monthly roundup of key developments of interest to business valuation experts.

D&P lowers U.S. normalized risk-free rate to 2.5%

Duff & Phelps has decreased its recommended U.S. normalized risk-free rate from 3.0% to 2.5% for use as of June 30, 2020, according to a client alert.

Using a size premium could trigger Daubert trouble, says new article

Adding a size premium to the cost of equity could make an expert’s testimony subject to a Daubert challenge, says Clifford Ang (Compass Lexicon) in a recent article.

Class-Action Litigation Involving ERISA/ESOP Valuation Issues

Join James F. Joyner and attorney Richard Pearl for unique insight into ESOPs and valuation principles. The general trend in ESOP transactions and valuation has been to acquiesce to fundamental changes because of the threat of litigation, even though ERISA or valuation principles do not require changes. Many defendants have been unable to adequately educate courts on some key issues. Get both the valuation and attorney perspective on how to address these issues.

BVR Briefing – The Real Story of COVID-19 For Valuation and Litigation Experts

September 2020 PDF

Mark Dietrich

Business Valuation Resources, LLC

Healthcare valuation expert Mark Dietrich (Mark O. Dietrich CPA, PC) has done over a hundred hours of research digging into the “science” of COVID-19—its origin, how it spreads, protection methods, testing, and other issues. You might wonder what all of this has to do with the valuation and financial community.  The answer is that for the economy to recover, these matters must be understood.  Learn more >>

More concern about the validity of the size premium factor

Most business valuers consider a size premium when calculating cost of capital for financial reporting purposes.

Assessing Additional Economic Risk Due to COVID-19

A template that can serve as a framework of thinking about the impact of the coronavirus on a subject company. The author presents a series of questions that help assess the short- and long-term risks with respect to the subject company’s industry, physical operations, financial issues, and firm management.

Valuing Residential and Commercial Construction Companies

Cash flow seasonality, bid requirements, license particulars, economic forces, and ubiquitous litigation are all hallmarks of the residential and commercial construction industries and all unique factors when appraising a construction company. Join What it’s Worth guide author and expert Pasquale Rafanelli for a full inspection of residential and commercial construction company valuation issues from accounting methods to value drivers. Avoid the common valuation mistakes that appraisers make and learn to answer the one question on ...

The Balance Sheet and its Correlation to Company Specific Risk

The pandemic is teaching us that businesses, small and large, and their balance sheets are important not just from handling a pandemic, but also from sustaining operations. Understanding assets, and which matter, will help analysts determine the specific company risks. Expert Josh Shilts discusses which categories are important in understanding risk and what ratios and other analyses can be used to measure risk. Identifying and linking balance sheet financials to company-specific risk is a critical ...

New business valuation resource from Professor Fernandez captures low market returns

Pablo Fernandez continues to release research that may assist UK business valuers working on reports with valuation dates in Q1 2020.

How to value uncertainty whilst keeping your clients’ confidence

Chris Thorne tells BVWire—UK that ‘most valuer’s Inboxes at the moment are full of comment about the difficulties of undertaking valuations,’ but he’s still receiving requests for advice about ‘providing a suitable warning in their reports that their valuations are subject to material valuation uncertainty.’

AICPA issues FAQs on valuation considerations related to the CARES Act

The latest in a series of very useful material from the AICPA is a document that includes FAQs that address questions about the impact of the CARES Act on business valuation.

Mercer using a 1% COVID-19 risk premium—for now

Veteran business valuer Chris Mercer (Mercer Capital) was a keynote speaker at the New York State Society of CPAs Business Valuation/Litigation Services Conference, which was held online on May 18.

Refinitiv and S&P Global both enhance sustainability ‘ESG’

The two big financial data providers, Refinitiv and SPGI, released improvements to their methodologies to score listed company performance across social value themes including emissions, environmental product innovation, diversity and inclusion, human rights, and shareholder access.

BVU News and Trends May 2020

A monthly roundup of key developments of interest to business valuation experts.

Volatility Adjustments for Industry, Size and Leverage

How well do you understand the theory and application of industry, size, and leverage adjustments for estimating equity volatility? Do you feel confident explaining it to a new analyst? A client? A judge? It may be time to get more confident. Join James Herr for a discussion of the basic concepts around applying volatility estimates in valuation, covering common pitfalls when calculating the basic volatility measure. Learn the differences between equity and asset volatilities, and ...

AICPA issues FAQs on valuing distressed or impaired businesses

Strong companies may see the current pandemic as an opportunity to fortify their balance sheets and other assets, according to the AICPA’s FAQs on Valuation Considerations When Valuing Distressed or Impaired Businesses.

Adult Nightclubs: Company-Specific Risk at the Extreme

David Shindel (ShindelRock) and Rod Burkert (Burkert Valuation Advisors) pull back the curtains of adult clubs to reveal their operating characteristics, special risks, and valuation nuances that push the limits of company-specific risk.

BVU News and Trends April 2020

A monthly roundup of key developments of interest to business valuation experts.

Valuing Distressed and Impaired Companies in the Time of Coronavirus

The Coronavirus Pandemic has created perhaps the most unusual economic downturn at least in our lifetimes and likely in the past 100 years. For Americans, the Pandemic stopped in its tracks one of the most explosive economic growth and expansion in many years, if ever. Overnight almost, businesses that were economically sound and growing were turned into distressed and impaired businesses. Jim Alerding will analyze the valuation perspective needed to value a distressed or impaired ...

Duff & Phelps raises US ERP from 5.0% to 6.0% for 1Q valuation dates

D&P has increased its recommended U.S. equity risk premium (ERP) from 5.0% to 6.0% for use as of 25 March 2020.

201 - 225 of 317 results